The US government has temporarily halted new funding for gain-of-function research on influenza, MERS and SARS viruses. Gain-of-function studies are defined as “research that improves the ability of a pathogen to cause disease.” The stoppage applies to research that “may be reasonably anticipated to confer attributes to influenza, MERS or SARS viruses such that the […]
Many seed and pesticide companies are investing in the search for biological pesticides. Some bacteria and small fungi repel pests on plants, and promote beneficial microflora and absorption of nutrients for faster growth. The companies want to use these microorganisms in new products for coating seeds or spraying on plants. Companies are seeking increased diversity […]
This month, the Europe University Association’s Public Funding Observatory released a report on public funding of EU institutes of higher education. The report reveals the complex factors underlying this funding. The wide range across the EU in funding often reflected the economic situation of countries over the past six years. Twenty states (or other units) […]
On the verge of a major correction in early October, US equity markets rebounded fervently to end the month in positive territory. The Dow Jones Industrial Average and S&P 500 climbed 2.0% and 2.3%, respectively, in October to close at record highs. The NASDAQ advanced 3.1%. The US markets were encouraged by corporate earnings reports, […]
Coinciding with ASHG 2014, several firms announced new partnerships in highly competitive markets. Affymetrix announced a multiyear supply agreement with Arosa Diagnostics, which will use Affymetrix instruments and arrays as part of its Harmony noninvasive prenatal test for Trisomy 21 in fetuses, allowing wider adoption of the test. Arosa’s DANSR (Digital Analysis of Selected Regions) […]
London, UK 10/7/14—Diploma, a publicly held supplier of specialized products and services, has acquired 80% of Technopath. Based in Ireland with 40 employees, Technopath supplies biotechnology, clinical-laboratory and medical products in Ireland and the UK. For the year ending August 31, it had sales of £12 million ($19 million = £0.62 = $1). Diploma Chief […]
Lansing, MI 10/1/14—Neogen, a supplier of products for food and animal safety, has acquired BioLumix for an undisclosed amount. Based in Michigan, BioLumix manufactures and markets automated systems for the detection of microbial contaminants. “The combination also settles litigation of several years between the two companies and benefits existing customers of both companies moving forward,” […]
Jena, Germany 10/1/14—Analytik Jena has sold 50% of its share in AJZ Engineering, its projects company, to ATG Consulting & Controlling. The agreement includes an option to sell the remaining shares by December 31, 2015. “Our aim is to position AJZ Engineering for the future. In line with that, we want to act for the […]
St. Louis, MO 10/3/14—Sigma-Aldrich has agreed to acquire Cell Marque for an undisclosed amount. Cell Marque designs, develops and manufactures antibody reagents and kits for immunohistochemistry. “We expect that Cell Marque’s strong in vitro diagnostic (IVD) antibody product lines and solid relationships with pathologists and companies that provide automated staining instrumentation will broaden the diagnostic-health […]
Waltham, MA 10/29/14—PerkinElmer has acquired Ceiba Solutions, a company that provides science- and lab-IT software and services and offers IT services and emerging software platforms. Financial details were not disclosed. PerkinElmer will integrate Ceiba’s capabilities into its OneSource services, which include Lab IT. “As customers seek solutions and business models to help drive more productive […]
Pay Invoice
Latest Blogs
-
NIH Disruptions and Lab Tool Companies: Stocks React
April 30, 2025 1:17 pm
-
Federal R&D Obligations for the NIH Decline in FY24
March 27, 2025 3:02 pm
-
Paving The Way for Change: 10x Genomics Announces Corporate Strategies for a Fruitful 2025
February 26, 2025 1:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
